cbdMD Inc.

AMEX: YCBD · Real-Time Price · USD
0.76
-0.09 (-10.54%)
At close: Aug 15, 2025, 3:58 PM
0.76
0.03%
After-hours: Aug 15, 2025, 07:32 PM EDT

cbdMD Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
19.59M 19.22M 19.48M 20.64M 21.58M 23.45M 24.16M 26.3M 28.78M 32.17M 35.4M 37.34M 39.3M 41.47M 44.48M 46.39M 46.46M 44.06M
Cost of Revenue
7.38M 7.38M 7.77M 7.83M 8.33M 8.76M 9.18M 9.91M 10.29M 11.25M 13.07M 14.23M 14.94M 15.39M 14.5M 15.78M 16.16M 15.24M
Gross Profit
12.22M 11.84M 11.71M 12.81M 13.25M 14.68M 14.98M 16.4M 18.49M 20.91M 22.34M 23.11M 24.37M 26.08M 29.99M 30.61M 30.31M 28.82M
Operating Income
-1.27M -2.34M -3.32M -18.22M -19.66M -19.51M -22.49M -22.25M -22.78M -26.39M -47.49M -39.52M -43.84M -43M -19.62M -17.13M -11.8M -13.23M
Interest Income
11.4K 11.4K 418.00 69.95K 69.95K 69.95K 98.65K 29.12K 29.12K 29.12K n/a n/a n/a n/a n/a n/a n/a 35.61K
Pretax Income
-158.72K -2.69M -3.7M -19.42M -21.65M -19.98M -22.94M -21.69M -51.56M -54.88M -70.08M -58.61M -25.33M -33.72M -24.29M -26.5M -37.08M -9.15M
Net Income
-1.16M -2.69M -3.7M -19.42M -21.65M 41.92M 37.96M 38.2M 7.34M -57.53M -71.73M -59.13M -24.95M -33.16M -23.39M -26.63M -37.12M -9.82M
Selling & General & Admin
8.52M 11.73M 12.25M 12.23M 13.34M 14.04M 16.54M 19.9M 21.91M 27.08M 31.25M 35.47M 40.57M 41.31M 39.34M 37.57M 33.4M 33.44M
Research & Development
35.24K 37.34K 39.02K 32.87K 47.33K 101.39K 173.04K 240.12K 329.31K 424.24K 633.39K 912.46K 1.47M 1.4M 1.42M 1.45M 799.72K 717.69K
Other Expenses
4.93M 2.41M 3.02M -210.39K -951.04K -424.13K n/a 3.35M 5.37M 6.14M 4.42M 6.38M 6.3M -4.78M -13.36M -16.22M -25.75M 4.38M
Operating Expenses
13.49M 13.83M 14.61M 17.39M 19.27M 20.9M 24.25M 26.57M 29.18M 35.22M 39.56M 44.45M 50.03M 50.9M 49.6M 47.74M 42.1M 42.05M
Interest Expense
20.38K 31.14K 31.56K 31.56K 20.06K 3.61K 3.19K 3.19K 3.5K 3.64K 6.87K 6.87K 7.9K 16.42K 23.57K 23.57K 3.46M 3.45M
Selling & Marketing Expenses
2.81M 3.79M 4.18M 5.08M 6.05M 6.4M 6.91M 7.86M 9.68M 12.92M 15.44M 17.06M 18.63M 18.54M 17.57M 16.09M 13.01M 12.33M
Cost & Expenses
20.86M 21.56M 22.73M 25.56M 27.95M 29.66M 33.42M 36.47M 39.47M 46.47M 52.62M 58.67M 64.97M 66.29M 64.1M 63.52M 58.26M 57.29M
Income Tax Expense
2M 2M 1M 14.61M 14.61M -48.29M -48.29M -7.94M -7.94M 53.6M 53.61M -479.93K -376.93K -559.77K -895K 130K 34.78K 570.78K
Shares Outstanding (Basic)
77.84K 4.55M 4.31M 3.59M 2.96M 2.96M 2.96M 2.38M 1.35M 1.34M 1.36M 1.32M 1.31M 1.31M 1.28M 1.26M 1.26M 1.16M
Shares Outstanding (Diluted)
7.78M 4.55M 4.31M 3.59M 2.96M 2.96M 2.96M 2.38M 1.35M 1.34M 1.36M 1.36M 1.32M 1.31M 1.29M 1.28M 1.37M 1.19M
EPS (Basic)
-17.88 -0.2 -0.65 -7.53 -8.12 38.23 35.20 29.09 5.07 -43.21 -54.14 -45.03 -19.05 -25.7 -19.18 -22.22 -31.29 -8.31
EPS (Diluted)
-0.75 -0.2 -0.65 -7.53 -8.12 38.23 35.20 29.09 5.88 -42.39 -53.31 -44.19 -19.04 -24.93 -18.22 -21.27 -30.17 -7.96
EBITDA
1.41M -507.02K -1.35M -4.06M -6.22M -4.49M -7.3M 33.87M 4.05M 1.13M -14.07M -59.73M -26.61M -35.5M -26.18M -23.78M -27.1M -20.04M
EBIT
586.57K -2.41M -3.39M -5.8M -8.04M -6.38M -9.36M 31.07M 1.21M -2.11M -17.22M -62.46M -29.18M -37.56M -28.12M -25.64M -28.62M -21.19M
Depreciation & Amortization
1M 1.59M 1.82M 2.7M 2.77M 2.85M 2.93M 2.7M 2.75M 3.15M 3.16M 3.04M 2.88M 2.38M 2.25M 1.86M 2.4M 2.02M